Data as of 3:59pm ET
| +0.28 / +5.60%|
The 2 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 5.15, with a high estimate of 6.30 and a low estimate of 4.00. The median estimate represents a -2.46% decrease from the last price of 5.28.
The current consensus among 2 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.